Audited Standalone and Consolidated Financial Result for the quarter and financial year ended March 31, 2026
GSPCROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 2.3 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
GSP Crop Science reported strong full-year FY2025-26 results with standalone revenue of Rs 16,059 million (up 14% YoY) and net profit of Rs 898 million (up 19% YoY). Consolidated revenue was Rs 15,171 million with net profit of Rs 947 million. The company completed its IPO in March 2026, raising Rs 2,400 million in fresh equity, and currently holds Rs 1,538 million in cash and equivalents. EBITDA margin stood at 9.5%. Auditors MSKC & Associates issued an unmodified (clean) opinion with no qualifications. The board recommended a dividend of Rs 1 per share (10% payout) subject to shareholder approval. A new CFO was appointed and the company incurred Rs 44.41 million additional provision due to new labour code implementation.
The company delivered solid double-digit growth in both revenue and profit, with a clean audit and strong cash position post-IPO. The dividend declaration signals confidence, though growth rates fell short of high-threshold triggers. Shareholders can expect stable performance with improved financial flexibility from the IPO proceeds.